Vium Overview
- Year Founded
-
2013

- Status
-
Acquired/Merged
- Employees
-
51

- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.6M
Vium General Information
Description
Provider of digital biomarkers intended to assist in pre-clinical drug research. The company's biomarkers are derived from artificial intelligence, machine learning and sensor technology and assists in accelerating the pre-clinical drug discovery and development pipeline, enabling researchers and drug developers to obtain improved insights into disease progression and take better decisions on which compounds should be advanced to the clinic.
Contact Information
Website
www.vium.com(Operating Subsidiary)
Corporate Office
- 411 Borel Place
- Suite 616
- San Mateo, CA 94402
- United States
Corporate Office
- 411 Borel Place
- Suite 616
- San Mateo, CA 94402
- United States
Vium Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 28-Jul-2020 | $2.6M | Completed | Generating Revenue | ||
5. Debt - PPP | 13-Apr-2020 | Completed | Generating Revenue | |||
4. Early Stage VC (Series B) | 21-Jun-2018 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 09-Jun-2015 | Completed | Generating Revenue | |||
2. Early Stage VC (Series A1) | 28-Oct-2014 | $8.8M | $9.9M | Completed | Generating Revenue | |
1. Seed Round | 24-Mar-2014 | $1.14M | $1.14M | Completed | Startup |
Vium Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A4 | ||||||||
Series A3 | ||||||||
Series A2 | 283,128 | $0.000100 | 8% | $2.26 | $2.26 | 1x | $2.26 | 2.21% |
Series A1 | 3,132,184 | $0.000100 | 8% | $2.83 | $2.83 | 1x | $2.83 | 24.29% |
Vium Comparisons
Industry
Financing
Details
Vium Competitors (5)
One of Vium’s 5 competitors is InterAx, a Venture Capital-Backed company based in Villigen, Switzerland.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
InterAx | Venture Capital-Backed | Villigen, Switzerland | ||||
Tierra (Discovery Tools (Healthcare)) | Venture Capital-Backed | San Leandro, CA | ||||
XtalPi Technology | Formerly VC-backed | Shenzhen, China | ||||
Kymera Therapeutics | Formerly VC-backed | Watertown, MA | ||||
CrossBeta Biosciences | Formerly VC-backed | Utrecht, Netherlands |
Vium Patents
Vium Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190191665-A1 | System and method of measured drug efficacy using non-invasive testing | Inactive | 21-Dec-2017 | ||
US-10789432-B2 | Tracklets | Active | 20-Dec-2017 | ||
US-20190188425-A1 | Tracklets | Active | 20-Dec-2017 | ||
US-10463017-B2 | Device and method for multi-dimensional classification of rodent vocalizations | Active | 03-Aug-2017 | ||
US-20190037801-A1 | Device and method for multi-dimensional classification of rodent vocalizations | Active | 03-Aug-2017 | A01K1/031 |
Vium Signals
Vium Former Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
AME Cloud Ventures | Venture Capital | Minority | ||
Brad Murphy | Angel (individual) | Minority | ||
Build Collective | Venture Capital | Minority | ||
Christine McCaull | Angel (individual) | Minority | ||
DCVC | Venture Capital | Minority |
Vium FAQs
-
When was Vium founded?
Vium was founded in 2013.
-
Where is Vium headquartered?
Vium is headquartered in San Mateo, CA.
-
What is the size of Vium?
Vium has 51 total employees.
-
What industry is Vium in?
Vium’s primary industry is Discovery Tools (Healthcare).
-
Is Vium a private or public company?
Vium is a Private company.
-
What is the current valuation of Vium?
The current valuation of Vium is
. -
What is Vium’s current revenue?
The current revenue for Vium is
. -
How much funding has Vium raised over time?
Vium has raised $53.9M.
-
Who are Vium’s investors?
AME Cloud Ventures, Brad Murphy, Build Collective, Christine McCaull, and DCVC are 5 of 10 investors who have invested in Vium.
-
Who are Vium’s competitors?
InterAx, Tierra (Discovery Tools (Healthcare)), XtalPi Technology, Kymera Therapeutics, and CrossBeta Biosciences are competitors of Vium.
-
When was Vium acquired?
Vium was acquired on 28-Jul-2020.
-
Who acquired Vium?
Vium was acquired by Recursion Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »